Interactions with different partners enables proteins to have different functions in different cells. The numerous potential interaction partners that have been identified for many proteins indicates that the number of protein complexes in eukaryotes is much greater than the number of proteins encoded by their genomes. Combinatorial protein interactions are central to the developmental complexity and evolutionary adaptability of these organisms.
Protein interactions have been investigated using a number of approaches. Many of the experimental approaches that enable the direct detection of interactions, such as co-precipitation and co-purification, require the removal of the proteins from their normal environment. By contrast, approaches that enable studies of protein interactions in their normal environments, such as genetic analysis of compensatory mutations, depend on the indirect consequences of protein interactions. The combined use of genetic and biochemical approaches has led to the identification of thousands of potential protein interactions, but the cell specificity and the subcellular localization of most of these interactions remains unknown.
Direct visualization of protein complexes in living cells enables the investigation of interactions in their normal environment. Two principal methods have been used to visualize interactions of protein complexes in living cells. The first technique, fluorescence resonance energy transfer (FRET), is based on changes in the fluorescence intensities or the lifetimes of two fluorophores that are brought sufficiently close together [1] [2] [3] . The second technique, bimolecular fluorescence complementation (BiFC), is based on the formation of a fluorescent complex by fragments of fluorescent proteins for which association is facilitated by the interaction between the proteins that are fused to these fragments 4, 5 (FIG. 1) . Other methods, such as fluorescence cross-correlation spectroscopy, have also been used 6 . Studies of protein interactions using the FRET assay have been described in several recent reviews [1] [2] [3] . This article focuses on the interactions that have been visualized using the BiFC assay and on the principles and assumptions that underlie this approach. A fundamental difference between the FRET and BiFC approaches is that FRET analysis is based on the difference in fluorescence intensity or lifetime when two fluorophores are in the same complex and when they are alone. By contrast, BiFC analysis is based on the formation of a fluorescent complex from non-fluorescent constituents. BiFC analysis is therefore potentially more sensitive, and it avoids interference from changes in the fluorescence intensity or the lifetime that are caused by cellular conditions unrelated to protein interactions. As discussed in detail below, this also prevents the use of the BiFC assay for the analysis of real-time complex formation.
A problem for protein interaction studies is that most proteins have multiple partners in the cell, so, under native conditions, only a subpopulation interacts with any particular partner. This problem is often solved by the overexpression of the proteins of interest to outcompete the endogenous interaction partners and to drive complex formation. This strategy carries the risk that protein overexpression produces non-native complexes and can alter the properties of the complexes that are formed. One advantage of the BiFC analysis is that the non-native complexes that are formed are invisible, enabling selective visualization of the complex that is under investigation.
BiFC assay
Many proteins can be divided into fragments that can interact to produce a functional complex. However, no general strategy for the design of such fragments has been articulated. Experimental applications of protein-fragment complementation are therefore crucially dependent on the identification of fragments that can associate with each other under relevant conditions (see TABLE 1 for a representative subset). Complementation assays that use fragments of different proteins have different properties. BiFC has the advantage that a complex can be directly visualized in living cells without the need for staining with exogenous molecules.
BiFC analysis enables the visualization of protein interactions in vivo with minimal perturbation of the normal cellular environment (FIG. 1) . Conditional fluorescence complementation was first shown by the expression of fragments of enhanced yellow fluorescent protein that were fused to either the basic-region leucine zipper (bZIP)-domain or Rel-family proteins in mammalian cells fragments produce fluorescent complexes when they are fused to several structurally dissimilar interaction partners (see below). The BiFC approach is therefore generally applicable for the visualization of protein interactions in living cells. BiFC analysis does not require structural information about the interaction partners. The association between the fluorescentprotein fragments does not require that the interaction partners position the fragments either in a specific orientation or within a fixed distance from each other. Nevertheless, steric constraints can prevent the association of the fragments within a complex. Therefore, peptide linkers between the fragments and the interaction partners might facilitate the association of fragments.
The interaction partners also do not need to form a complex with a long half-life, as potentially transient interactions can be trapped by the association of the fluorescentprotein fragments
. It is not necessary for a large proportion of the interaction partners to associate with each other because cells have low background fluorescence and unassociated fragments do not interfere with the detection of the complex.
An essential criterion for the fusion proteins that are used in the BiFC analysis is that the fluorescent-protein fragments must not associate with each other efficiently in the absence of an interaction between the proteins that are fused to these fragments. Spontaneous association between the fragments can be influenced by the nature of the fusion proteins; therefore this must be tested for each case. Expression of some fluorescent-protein fragments that are not fused to an interaction partner produces strong fluorescence 7, 8 . The fluorescence produced by the spontaneous association of the fragments that are used for BiFC analysis is frequently reduced when the fragments are fused to proteins that do not interact with each other. In many cases, high-level expression of fusion proteins results in the formation of a fluorescent complex in the absence of specific interactions between the proteins that are fused to the fragments. It is therefore desirable to express the fusion proteins at levels comparable to their endogenous counterparts, and to test the effects of mutations, which eliminate the interaction between these proteins, on fluorescence complementation.
As in the case of all approaches that make use of fusion proteins, it is necessary to consider the possibility that the fusions affect the functions of the interaction partners. Ideally, the fusion proteins should be tested by substituting them for their endogenous counterparts in vivo. However, this approach is practical only in prokaryotes and yeast, so alternative assays to test the functions of the fusion proteins must be used in the other eukaryotes. It is also important to examine the potential consequences of the stabilization of the interaction between the fusion proteins by bimolecular fluorescent complex formation
. Trapping of the interaction partners by the association of the fluorescentprotein fragments can alter the properties of the complex.
Visualization of interactions using BiFC
BiFC analysis has been used to study interactions among a wide range of proteins in many cell types and organisms (TABLE 2, Supplementary information S1 (table)). cent-protein fragments can be enhanced by increasing their molecular proximity, such as when they are tethered in the same macromolecular complex. Fusion proteins that will produce an optimal signal must generally be determined empirically. For true in vivo interaction partners, it is almost always possible to find fusion proteins that produce a detectable signal. The fluorescence intensity produced by bimolecular fluorescence complementation (BiFC) in living cells is generally less than 10% of that produced by intact fluorescent proteins. It is likely that only a subset of the fragments associate with each other, as the fluorescence intensity of BiFC complexes that is produced in vitro is comparable to the intensity produced by intact fluorescent proteins Subnuclear localization. The BiFC assay has been used to study interactions among many structural classes of transcription factors 4, 5, [9] [10] [11] [12] [13] [14] [15] [16] [17] . These studies have provided a more refined understanding of protein interactions in the nucleus and their effects on subnuclear localization (FIG. 1) . In many cases, the localization of a protein complex differs from the localizations of the interaction partners, which shows that complex formation can regulate localization 4, 10, 11 . Further studies of the mechanisms that regulate subnuclear localization might contribute towards our understanding of the roles of compartmentalization in nuclear functions.
Enzyme-substrate complexes. The BiFC assay has also been applied for the identifi cation of several enzyme-substrate inter actions, including those of ubiquitin ligases, kinases and guanine nucleotideexchange factors [18] [19] [20] [21] [22] [23] . Determination of the substrate specificities and sites of action of these enzymes in vivo has yielded new hypotheses for their functions. For example, in Saccharomyces cerevisiae, it has been shown that the ubiquitin E3 ligase Grr1 interacts with Hof1, a regulator of cytokinesis within the bud neck during the M phase of the cell cycle. Degradation of Hof1 by Grr1 is an important step for actomyosin contraction during cytokinesis in yeast 20 .
Signal transduction cascades.
Using the BiFC assay, interactions among many signalling proteins in signal transduction networks have been visualized. The SMAD family of transcription factors mediates responses to transforming growth factor-β (TGFβ) signalling. BiFC analysis has shown that SMAD3-SMAD4 complexes are localized to the nucleus, whereas the association of SMAD3 with AKT/PKB (protein kinase B) prevents its nuclear translocation 22 . BiFC analysis has also been particularly valuable for the visualization of membrane protein interactions because of the potential role of the membrane environment in controlling complex formation 19, [24] [25] [26] [27] . Contrary to expectation, the constrained mobilities of membrane proteins apparently neither prevent the association of the fluorescent-protein fragments nor eliminate the requirement for specific protein interactions.
Regulation of complex localization. The BiFC assay is ideally suited for the visualization of the subcellular localization of protein complexes. Heterodimers that are formed by Jun and ATF2 transcription factors are cytoplasmic in unstimulated cells, and are translocated to the nucleus upon the stimulation of stress-activated protein kinases 4 .
Complexes that are formed between Max and different Myc-and Mad-family transcription factors are localized to different subnuclear locations 10 . Upon isopreterenol stimulation, the β-and γ-subunits of the heterotrimeric G-protein internalize as a complex that is separate from the β-adrenergic receptor 24, 28 . A complex that is formed by the guanine nucleo tide-exchange factors GBF1 and the small GTPase ARF1 (ADP-ribosylation factor-1) is recruited to the Golgi in cells stimu lated with brefeldin A 21 . Similarly, a complex that is formed by the BCL2-family proteins BIF1 and BAX is relocated to mitochondria in cells induced to undergo apoptosis 29 . The BiFC assay therefore enables the visualization of the recruitment of protein complexes to different subcellular locations.
Box 1 | Pathway for bimolecular fluorescent complex formation
The dynamics of bimolecular fluorescence complementation (BiFC) have been investigated to elucidate the pathway for fluorescent complex formation 4 . In vitro studies using purified proteins indicate that the initial associations between the fusion proteins (complex I) are mediated by the interaction partners (indicated by coloured cylinders). This interaction occurs in competition with alternative interaction partners, which could form mutually exclusive interactions (complexes II). The association between the fluorescent-protein fragments is slower and produces an intermediate (complex III), which undergoes slow maturation to produce the peptide fluorophore (complex IV). This causes a delay in detection of the bimolecular fluorescent complex that depends on the strength of the signal, the background fluorescence and the sensitivity of the detector. The formation of complexes III and IV are irreversible under some conditions 4 , but they seem to be reversible under other conditions 25, 36, 58 , perhaps in the presence of cellular chaperones. The spectral characteristics of the bimolecular fluorescent complex and the intact fluorescent protein are indistinguishable, which indicates that the β-barrel structure and the tripeptide fluorophore are likely to be identical. Fluorescent-protein fragments that have not associated with complementary fragments undergo irreversible misfolding in vitro (complexes V). This non-productive folding pathway of the isolated fluorescent-protein fragments prevents fluorescence complementation between fragments that are fused to proteins that do not interact with each other in cells. The fates of fusion proteins that contain unpaired fluorescent-protein fragments in cells are not known, but at least some such fusions are not degraded faster than their endogenous counterparts 35 .
Interactions involving post-translational modifications. Many interactions require specific post-translational modifications, and the requirements for the modifications can be tested in vivo using the BiFC assay. The bromodomain protein BRD2 binds selectively to acetylated histones, and complementation between these proteins requires both the bromodomain of BRD2 and the histone H4 tail that contains the acetylation site 13 . Fluorescence complementation between the ERGIC53 receptor and cathepsin-Z and cathepsin-C requires the lectin-binding domain of ERGIC53, which indicates that these interactions require ligand glycosylation 30 . BiFC can therefore be used to monitor changes in post-translational modifications that alter protein interactions in cells.
Macromolecular complexes and molecular scaffolds. The interaction that brings together the fluorescent-protein fragments does not need to be direct. Fusion proteins that are brought together by assembly in a macromolecular complex can produce bi molecular fluorescent complexes in the absence of direct contact between the proteins that are fused to the fragments. Likewise, fusion proteins that bind to the same molecular scaffold might support fluorescence complementation even if the fusion partners do not contact each other directly. Using this principle, RNA binding by the human zipcode-binding protein-1 orthologue (IMP1), the iron regulatory protein-1 (IRP1), the fragile-X mental-retardation protein (FMRP), and the human Staufen-1 homologue (STAU1) have been visualized in living cells 31 . Likewise, co-occupancy by zinc-finger DNAbinding proteins on oligonucleotides has been detected in vitro 32 . Therefore, although the association of fluorescent-protein fragments in the BiFC assay is bimolecular, this assay is not limited to the visualization of binary interactions.
BiFC studies in different organisms.
The BiFC assay has been used to study inter actions in various species from many different phyla (TABLE 2) . The BiFC assay is therefore likely to be generally applicable for the visualization of protein interactions in almost every aerobically grown cell type and organism that can be genetically modified to express proteins that are fused to fluorescentprotein fragments. All of the studies in higher eukaryotes, or cultured cells from these organisms, have used transient expression of the fusion proteins. Under these conditions, the levels of protein expression in individual cells are difficult to establish. Future studies using transgenic organisms with stable expression of the fusion proteins in specific tissues will probably have an even greater impact on the understanding of protein interactions in the physiological context.
Interaction screens.
Complementation assays, and in particular the yeast twohybrid transcription-activation assay, have been used to identify new interaction partners for many proteins. The Ft1 protein was identified as an interaction partner of AKT/PKB using a BiFC-based library screening approach 33 . The advantage of BiFC-based screens is that the interactions can be detected within the cell, and the effects of stimuli on the interaction can be tested directly. One limitation of BiFC-based screens is that the differences in protein expression levels under experimental conditions probably influence which partners can be identified. Nevertheless, BiFC analysis has the potential to identify partners that interact with a protein of interest under specific cellular conditions. BiFC analysis could also be used to identify synthetic molecules or cellular factors that can modulate protein interactions.
Simultaneous visualization of complexes
The transformation of cell biology that was caused by the discovery of green fluorescent protein has been accelerated by the identification of numerous variants with altered spectral and photophysical characteristics 1 . Bimolecular fluorescent complexes that are formed through the association of fragments from different fluorescent proteins have spectra that differ from those of complexes that are formed through the association of fragments from the same fluorescent protein 5, 34 . The spectral differences between these complexes enable the simultaneous visualization of multiple protein complexes (FIG. 2) . Direct comparison of the distributions of multiple complexes in the same cell eliminates the need to find markers for subcellular compartments that co-localize with the complex. It also helps to determine whether differences in complex localizations are a direct consequence of the differences between their localization signals or an indirect consequence of the differences between the effects of these complexes on cellular functions. The latter possibility is difficult to exclude when comparing the distributions of the complexes in different cells. The multicolour BiFC assay can also be used to investigate the competition between mutually exclusive interaction partners for complex formation with a common partner 5, 10 . When two alternative inter action partners that are fused to fragments of different fluorescent proteins are expressed with a limiting amount of a common partner that is fused to a dually complementary fragment, different quantities of complexes are formed with each partner. The proportion of complexes that are formed with each partner reflects the relative efficiencies of complex formation. As bimolecular fluorescent complex formation is not reversible under all conditions, the relative efficiencies of complex formation do not necessarily reflect the equilibrium binding affinities of the interaction partners in the cell. Nevertheless, for complexes with dissociation rates that are faster than the rates of association between the fluorescent-protein fragments (half-life ∼ 1 min), it is probable that the relative amounts of the bimolecular fluorescent complexes that form with each interaction partner reflect the relative efficiencies of complex formation between the unmodified proteins. Comparisons of the efficiencies of complex formation between alternative interaction partners requires normalization for the differences between the efficiencies of association of the different fluorescent-protein fragments and the resulting fluorescence intensities 5, 10 . The influence of steric constraints on the association between fragments fused to different interaction partners can be tested by using linker sequences of different lengths.
Applications of multicolour BiFC analysis.
The multicolour BiFC assay has been used to determine the relative efficiencies of dimerization among the bZIP domains of the Fos (bFos), Jun (bJun) and ATF2 (bATF2) transcription factors in mammalian cells. In living cells, bFos-bJun heterodimers form more efficiently than either bFos-bATF2 or bJun-bATF2 heterodimers 5 . Jun-ATF2 heterodimers are thought to regulate the expression of many genes in response to cell stress. It is therefore plausible that heterodimer formation is regulated in response to cell stress, or that regions outside the bZIP domains influence the dimerization specificities of the proteins.
Multicolour BiFC analysis has also been used to compare the relative efficiencies of Max interactions with the basic helix-loophelix-zipper domain of Myc (bMyc) to interactions with the Mad-family transcription factors in mammalian cells 10 . Heterodimers that are formed between Max and Myc promote cell proliferation, whereas heterodimers that are formed with Mad-family proteins promote quiescence or differentiation in many cell types. As predicted based on in vitro studies, Max favours heterodimer formation with bMyc over homodimerization, and this preference is reversed by point mutations in the leucine zipper of Max. Surprisingly, Max formed heterodimers with MAD3 less efficiently than with bMyc, whereas it formed heterodimers with MAD4 more efficiently than with bMyc. Therefore, the relative amounts of Max heterodimers with Myc and the Mad-family proteins depend on the specific Mad-family proteins that are present in the cell.
Visualization of ubiquitin conjugates
Conjugation of ubiquitin-family peptides to a wide range of protein substrates functions as a mechanism that modulates the stability and the function of many proteins. A ubiquitin-mediated fluorescence complementation (UbFC) assay has been developed for the visualization of ubiquitin conjugates in living cells 35 . In the UbFC approach, the fluorescent-protein fragments are fused to ubiquitin and to a putative substrate protein.
The covalent attachment of ubiquitin to a substrate can facilitate association between the fragments, thereby enabling the selective visualization of the ubiquitin conjugate (FIG. 3) . The UbFC assay has many of the same characteristics of the BiFC assay. Of particular significance is its capacity to visualize a small subpopulation of modified proteins when high levels of unmodified proteins are present. This capacity is crucial for studies of ubiquitin-family peptide modifications because the proportion of most proteins that are conjugated by a ubiquitin-family peptide at any one time is small.
As in the case of the BiFC assay, it is essential to establish whether mutations that prevent ubiquitination of the substrate affect the complementation signal. It is possible that steric constraints allow the association of the fluorescent-protein fragments only The UbFC assay has been used to visualize ubiquitin-family peptide conjugates of the Jun protein 35 . Surprisingly, ubiquitinated Jun is exported from the nucleus and is translocated to lysosomes for degradation. The UbFC assay can also be used to detect modifications by other ubiquitin-family peptides, such as the small ubiquitin-like modifier-1 (SUMO1). UbFC analysis showed that modification of Jun by SUMO1 induced its translocation to subnuclear foci 35 . Multicolour UbFC analysis showed that Jun modification by ubiquitin compared to modification by SUMO1 induced translocation to different locations within the same cell. Recent studies have revealed a broad range of functions for ubiquitinfamily peptide modifications, and more will undoubtedly be discovered. The direct visual ization of these conjugates using the UbFC assay is a valuable tool for the investigation of these modifications in living cells.
Future prospects and challenges
Studies of protein interactions and modifications have produced great advances in our understanding of biological regulatory mechanisms. The ability to visualize interactions and modifications in living cells and organisms is a crucial requirement for further progress in our understanding of these mechanisms. The BiFC and UbFC assays are valuable tools for the visualization of non-covalent interactions and ubiquitinfamily peptide conjugation in vivo. Studies using these assays have established that they are generally applicable for the investigation of interactions among various structurally and functionally dissimilar proteins as well as modifications by different ubiquitinfamily peptides. These assays have been used in various organisms and cell types, and there do not seem to be any barriers to their use in an ever-expanding array of experimental systems.
The present generation of fluorescence complementation assays are powerful tools, but they have some characteristics that limit their usage. One of these limitations is the irreversible association of the fluorescentprotein fragments, at least under some conditions. A better understanding of the dynamics of bimolecular fluorescent complex formation in living cells, and the development of complementing fragments that minimally perturb the dynamic exchange of interaction partners would be valuable improvements. A second limitation is the intrinsic ability of fluorescent-protein fragments to associate with each other independently of an interaction between the proteins that are fused to the fragments. This main source of background signal in the BiFC assay varies depending on the type of fusion proteins that are involved and their levels of expression. The development of fluorescentprotein fragments with a reduced tendency for intrinsic association, but without a reduced ability to associate when brought together by a protein interaction, would make the assay less sensitive to the levels of protein expression. Finally, fluorescent protein engineering has produced an abundance of variants with useful characteristics 1 , but has not markedly increased the rates of the chemical reactions required for fluorophore formation. Given the importance of this transformation for all experiments using fluorescent proteins, the acceleration of the chemistry of fluorophore formation would be useful. Bimolecular fluorescent complexes with novel properties could be identified through the screening of combinatorial libraries of fluorescent-protein fragments.
The specificity of protein interactions in cells is determined to a great extent by the competition between mutually exclusive interaction partners. A better understanding of the factors that influence the relative efficiencies of complex formation, including localization, scaffolding, modifications, networks of alternative partners and ) assay is based on the association between fluorescent-protein fragments that are brought together by the covalent conjugation of ubiquitin that is fused to one fragment and a substrate that is fused to the complementary fragment. Lys residues to which ubiquitin and ubiquitin-like modifiers conjugate are represented by K. The fluorescent-protein fragments must be fused to the N-terminal ends of ubiquitin-family peptides because their C-terminal ends are essential for their conjugation to substrate proteins. Fusions to the N termini of ubiquitin and small ubiquitin-like modifier-1 (SUMO1) do not interfere with the activities of the enzyme complexes that conjugate these peptides to protein substrates. It is essential to determine if the conjugates that contain the fluorescent-protein fragments retain the biological functions of the unmodified conjugates. Because ubiquitin can be conjugated in different monomeric and polymeric configurations to substrates, it is important to establish that the stoichiometry and configuration of the ubiquitin con- intrinsic binding affinity, is essential for our understanding of the regulation of protein interactions. The multicolour BiFC assay is a tool that enables the investigation of many of these factors in the normal cellular environment. However, the efficiency of bimolecular fluorescent complex formation depends on both the efficiency of the interaction between the proteins under investigation and the efficiency of association between the fluorescent-protein fragments. Determination of the relative efficiencies of fluorescent-protein fragment association when they are present in different complexes remains an important challenge. Differences between these efficiencies can be evaluated on a case by case basis, but a general method for the quantitative comparison of the efficiencies of complex formation would make using the multicolour BiFC approach more straightforward.
Many biological processes occur asynchronously in different cells in a population. Studies of such processes at a population level can miss the relationships between the processes because these relationships are averaged over the entire population. The multicolour BiFC approach enables the simultaneous imaging of multiple protein interactions in the same cell. Comparison of several mole cular interactions in the same cell can identify relationships between the interactions in an asynchronous cell population.
Fluorescence complementation assays will undoubtedly continue to be used in new applications in the future. Studies of protein interactions in transgenic plants and animals will enable the investigation of the developmental and tissue-specific regulation of complex formation. The use of regulated vector systems to control fusion-protein expression in cultured cells will enable control of the levels of protein expression at more uniform levels. The use of native transcription regulatory regions and knockin expression constructs, when possible, will enable studies of the timing and the cell-type specificity of complex formation.
The BiFC approach could be used for purposes other than the study of protein interactions. The wide range of spectral variants that are produced by different combinations of fluorescent-protein fragments could be used for the combinatorial tagging of cells in studies of cell lineages and migration. The signal produced by the association of fluorescent-protein fragments could be used to study cell or organelle fusion and the resulting mixing of their contents. Many post-translational modifications could be imaged through the use of protein domains that specifically recognize the modifications. Ultimately, strategies for the simultaneous control and monitoring of protein interactions and modifications may be realized. [1] [2] [3] . Despite the undoubted theoretical utility of lipid rafts to many cell biological processes, the basic hypothesis that stable lipid rafts exist at all in biological membranes is under intense scrutiny 4, 5 . This is partly because lipid rafts, if they exist in resting cell membranes, are too small to be resolved by fluorescent microscopy and have no defined ultrastructure; therefore, proving their existence is problematic. This article will consider the biophysical properties of model membranes that underpin the lipid raft hypothesis, and the limitations of the biochemical approaches that have been used to study rafts in biological membranes that largely account for the current debate on the hypothesis mentioned above. After examining the challenges that are involved in correlating observations, which have been made in model and cellular membranes, I focus on synthesizing recent data on the size of lipid domains in model membranes with observations that have been obtained by imaging intact plasma membranes. These imaging approaches include single particle tracking (SPT), single fluorophore video tracking (SFVT), fluorescence resonance energy transfer (FRET), homo-FRET and electron microscopy (EM). On the one hand, these studies challenge the simplistic null hypothesis that lipid-based assemblies, such as lipid rafts, do not exist in biological membranes. On the other hand, it is timely to reconsider the raft hypothesis in the light of these new data because the consensus model that emerges is more complex than a simplistic notion of stable, freely diffusing lipid rafts. Some intriguing new questions about the structure and function of lipid rafts in the plasma membrane, which are posed by this revised raft model, will be discussed.
Biophysics and model membranes
Although the plasma membrane is a complex organelle, its basic structure consists of a phospholipid bilayer. Some insights into the behaviour of this basic structure might then be anticipated by analysing model membranes that consist of simple, hydrated phospholipid bilayers. An important property of such a model membrane is revealed as the temperature of the bilayer is progressively increased. At a temperature that is characteristic of the particular lipid species, the phospholipids undergo a phase transition from a solid ordered, or gel, phase (S o ) to a liquid disordered phase (L d ). The lateral mobility of the lipids, which is highly restricted in the S o phase, increases, and the acyl-side chains become disordered and no longer pack together tightly in rigid straight conformations. If the membrane also contains sufficient cholesterol, a third phase (liquid ordered (L o )) is possible. The L o phase is characterized by a high degree of acyl-chain ordering, which is typical of the S o phase, but with the translational disorder
